Metropolis Healthcare unveils Innovation Cell

07 July 2022 | News

To focus on molecular genomics, superspeciality pathology and companion diagnostics

Image Credit: Shutterstock

Image Credit: Shutterstock

Metropolis Healthcare has announced the launch of Metropolis Innovation Cell focusing on molecular genomics, super speciality pathology and companion diagnostics.

 

Under Innovation Cell, Metropolis is introducing various specialised tests related to pregnancy, cancer, infectious diseases and transplant management.

 

The company has introduced specialised tests for non-invasive genetic assessments for pregnancy management that can aid in the early detection of chromosomal abnormalities.

 

It has also launched BRCA1/BRCA 2 Genetic testing for Hereditary Breast and Ovarian Cancer (HBOC), and the molecular oncology pipeline for Lung and common cancers.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account